Phase 3
Completed N=37
Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.
Source: ClinicalTrials.gov NCT00212355 ↗Enrolled (actual)
37
Serious AEs
10.8%
Results posted
May 2014
Primary outcomePrimary: Safety and Efficacy — 37 participants
Summary
The purpose of this long-term study is to determine whether Zinc Acetate is effective and safe in the treatment of Wilson's disease among Japanese.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Safety and Efficacy |
37 | — |
Eligibility Criteria
Inclusion Criteria
- Wilson's disease(adult, infant, pregnant woman)
Exclusion Criteria
- Acute hepatitis
- Malignant tumor
Data sourced from ClinicalTrials.gov (NCT00212355). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.